tradingkey.logo
tradingkey.logo
Search

Bioversys Says Patent Claims For Its BV100 Drug Candidate Have Been Granted In China

ReutersMar 31, 2025 5:05 AM
facebooktwitterlinkedin

- BIOVERSYS AG BIOV.S:

  • PATENT AROUND BIOVERSYS' BV100 DRUG CANDIDATE HAS BEEN GRANTED, PROTECTING PROPRIETARY RIFABUTIN IV FORMULATION TECHNOLOGY IN CHINA

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI